Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,814 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin Toxicities.
Kim YS, Ji JH, Oh SY, Lee S, Huh SJ, Lee JH, Song KH, Son CH, Roh MS, Lee GW, Lee J, Kim ST, Kim CK, Jang JS, Hwang IG, Ahn HK, Park LC, Oh SY, Kim SG, Lee SC, Lim DH, Lee SI, Kang JH. Kim YS, et al. Among authors: kim st, kim sg, kim ck. Oncologist. 2020 Jan;25(1):e186-e193. doi: 10.1634/theoncologist.2019-0221. Epub 2019 Sep 6. Oncologist. 2020. PMID: 31492766 Free PMC article. Clinical Trial.
A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer.
Kim HJ, Lee NS, Lee SC, Bae SB, Kim CK, Cheon YG, Kim YS, Moon JH, Cho YD, Park SH, Lee KT, Park SK, Won JH, Park HS, Hong DS. Kim HJ, et al. Among authors: kim ck, kim ys. Cancer Chemother Pharmacol. 2009 Jul;64(2):371-7. doi: 10.1007/s00280-008-0883-7. Epub 2009 Jan 14. Cancer Chemother Pharmacol. 2009. PMID: 19142638 Clinical Trial.
Efficacy and safety of oxaliplatin, 5-Fluorouracil, and folinic Acid combination chemotherapy as first-line treatment in metastatic or recurrent gastric cancer.
Kim HJ, Eun JY, Jeon YW, Yun J, Kim KH, Kim SH, Kim HJ, Lee SC, Bae SB, Kim CK, Lee NS, Lee KT, Park SK, Won JH, Hong DS, Park HS. Kim HJ, et al. Among authors: kim sh, kim ck, kim kh. Cancer Res Treat. 2011 Sep;43(3):154-9. doi: 10.4143/crt.2011.43.3.154. Epub 2011 Sep 30. Cancer Res Treat. 2011. PMID: 22022292 Free PMC article.
Pathophysiological role of hormones and cytokines in cancer cachexia.
Kim HJ, Kim HJ, Yun J, Kim KH, Kim SH, Lee SC, Bae SB, Kim CK, Lee NS, Lee KT, Park SK, Won JH, Park HS, Hong DS. Kim HJ, et al. Among authors: kim sh, kim ck, kim kh. J Korean Med Sci. 2012 Feb;27(2):128-34. doi: 10.3346/jkms.2012.27.2.128. Epub 2012 Jan 27. J Korean Med Sci. 2012. PMID: 22323858 Free PMC article.
Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients.
Kim HJ, Yun J, Kim HJ, Kim KH, Kim SH, Lee TH, Lee SC, Bae SB, Kim CK, Lee NS, Moon JH, Park SH, Lee KT, Park SK, Won JH, Park HS, Hong DS. Kim HJ, et al. Among authors: kim sh, kim ck, kim kh. Oncol Lett. 2012 Jun;3(6):1314-1318. doi: 10.3892/ol.2012.637. Epub 2012 Mar 8. Oncol Lett. 2012. PMID: 22783441 Free PMC article.
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects.
Hwang IG, Kang JH, Oh SY, Lee S, Kim SH, Song KH, Son C, Park MJ, Kang MH, Kim HG, Lee J, Park YS, Sun JM, Kim HJ, Kim CK, Yi SY, Jang JS, Park K, Kim HJ. Hwang IG, et al. Among authors: kim hg, kim hj, kim sh, kim ck. Support Care Cancer. 2016 Jan;24(1):301-309. doi: 10.1007/s00520-015-2783-9. Epub 2015 Jun 4. Support Care Cancer. 2016. PMID: 26041481 Clinical Trial.
1,814 results